Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WHO Solidarity Trial Plus Sub-Study (Nepal)
NCT05273242Phase 4Unknown
- Sponsor
- Nepal Health Research Council
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of artesunate, imatinib, infliximab in coronavirus disease 2019 (COVID-19), sponsored by Nepal Health Research Council. Status: unknown.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05273242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05273242.